Wnt Activation by Wild Type and Mutant Myocilin in Cultured Human Trabecular Meshwork Cells

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Shen, Xiang ^a   Ying, Hongyu ^a   Yue, Beatrice Y J T ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOCILIN; PHALLOIDIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; WNT PROTEIN;

ARTICLE; CONTROLLED STUDY; FOCAL ADHESION; GENE; HUMAN; HUMAN CELL; MUTANT; MYOCILIN GENE; SIGNAL TRANSDUCTION; STRESS FIBER; TRABECULAR MESHWORK; WILD TYPE;

ACTINS; ADULT; CACO-2 CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSKELETAL PROTEINS; EYE PROTEINS; FOCAL ADHESIONS; GLYCOPROTEINS; HUMANS; INDOLES; MALEIMIDES; MIDDLE AGED; MUTATION; PHENOTYPE; PROTEINS; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; TRANSFECTION; WNT PROTEINS; YOUNG ADULT;

EID: 84866426074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044902     Document Type: Article

References (56)

1. Quigley HA, (2011) Glaucoma. Lancet 377: 1367-1377.
2. Kwon YH, Fingert JH, Kuehn MH, Alward WLM, (2009) Primary open-angle glaucoma. N Engl J Med 360: 1113-1124.
3. Bill A, (1975) The drainage of aqueous humor. Invest Ophthalmol Vis Sci 14: 1-3.
4. Yue BYJT, (1996) The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol 40: 379-390.
5. Zhou L, Fukuchi T, Kawa JE, Higginbotham EJ, Yue BYJT, (1995) Loss of cell-matrix cohesiveness after phagocytosis by trabecular meshwork cells. Invest Ophthalmol Vis Res 36: 787-795.
6. Stumpff F, Wiederholt M, (2000) Regulation of trabecular meshwork contractility. Ophthalmologica 214: 33-53.
7. Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS, (2009) Extracellular matrix turnover and outflow resistance. Exp Eye Res 88: 676-682.
8. Stamer WD, Acott TS, (2012) Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 23: 135-143.
9. Tian B, Gabelt BT, Geiger B, Kaufman PL, (2009) The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res 88: 713-717.
10. Fingert JH, (2011) Primary open angle genes. Eye 25: 587-595.
11. Wang N, Chintala SK, Fini ME, Schuman JS, (2001) Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 7: 304-309.
12. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, et al. (1997) Identification of a gene that causes primary open angle glaucoma. Science 275: 668-670.
13. Gong G, Kosoko-Lasaki O, Haynatzki GR, Wilson MR, (2004) Genetic dissection of myocilin glaucoma. Hum Mol Genet 13: R91-102.
14. Tamm ER, (2002) Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res 21: 395-428.
15. Nguyen T, Chen P, Huang W, Chen H, Johnson D, et al. (1998) Gene structure and properties of TIGR, an olfactomedin-related glycoprotein clones from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 273: 6341-6350.
16. Wentz-Hunter K, Shen X, Yue BYJT, (2003) Distribution of myocilin, a glaucoma gene product, in human corneal fibroblasts. Mol Vis 9: 308-314.
17. Ueda J, Wentz- Hunter K, Cheng EL, Fukuchi T, Abe H, et al. (2000) Ultrastructural localization of myocilin in human trabecular meshwork cells and tissues. J Histochem Cytochem 48: 1321-1329.
18. Mao W, Tovar-Vidales T, Yorio T, Wordinger RJ, Clark AF, (2011) Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma. Invest Ophthalmol Vis Sci 52: 8068-8075.
19. Wentz-Hunter K, Shen X, Okazaki K, Tanihara H, Yue BYJT, (2004) Overexpression of myocilin in cultured human trabecular meshwork cells. Exp Cell Res 297: 39-48.
20. Sakai H, Park BC, Shen X, Yue BYJT, (2006) Transduction of TAT-fusion proteins into the human and bovine trabecular meshwork. Invest Ophthalmol Vis Sci 47: 4427-4234.
21. Shen X, Koga T, Park BC, SundarRaj N, Yue BYJT, (2008) Rho GTPase and cAMP/PKA signaling mediates myocilin induced alterations in cultured human trabecular meshwork cells. J Biol Chem 283: 603-612.
22. Kwon H-S, Lee H-S, Ji Y, Rubin JS, Tomarev SI, (2009) Myocilin is a modulator of Wnt signaling. Mol Cell Biol 29: 2139-2154.
23. Jin T, Fantus IG, Sun J, (2008) Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of β-catenin. Cell Signal 20: 1697-1704.
24. Cadigan KM, Peifer M, (2009) Wnt signaling from development to disease: insights from model systems. Cold Spring Harb Perspect Biol 1: a002881.
25. Mii Y, Taira M, (2011) Secreted Wnt "inhibitors" are not just inhibitors: regulation of extracellular Wnt by secreted Frizzled-related proteins. Develop Growth Differ 53: 911-923.
26. Luo J, Chen J, Deng Z, Luo X, Song W, et al. (2007) Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest 87: 97-103.
27. Veeman MT, Acelrod JD, Moon RT, (2003) A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev Cell 5: 367-377.
28. Kühl M, Sheldahl LC, Park M, Miller JR, Moon RT, (2000) The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283.
29. De Iongh RU, Abud HE, Hime GR, (2006) Wnt/Frizzled signaling in eye development and disease. Front Biosci 11: 2442-2464.
30. Wang WH, McNatt LG, Pang IH, Millar JC, Hellberg PE, et al. (2008) Increased expression of the Wnt antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Invest 118: 1056-1064.
31. Braeuning A, Buchmann A, (2009) The glycogen synthase kinase inhibitor 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor. Drug Metabol Disposition 37: 1576-1580.
32. Osada T, Chen M, Yang XY, Spasojevic I, Vandeusen JB, et al. (2011) Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor response in tumors with activating APC mutations. Cancer Res 71: 4172-4182.
33. Kuroda T, Rabkin SD, Martuza RL, (2006) Effective treatment of tumors with β-catenin-T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Cancer Res 66: 10127-10134.
34. Wang W, Liu H, Wang S, Hao X, Lin L, (2011) A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis. Cell Res 21: 730-740.
35. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
36. Rao TP, Kuhl M, (2010) An updated overview on Wnt signaling pathways. A prelude for more. Cir Res 106: 1798-1806.
37. Dejana E, (2010) The role of Wn signaling in physiological and pathological angiogenesis. Cir Res 107: 943-952.
38. Yang Z, Liu G, Bollig-Fischer A, Haddad R, Tarca A, et al. (2009) Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer 125: 1613-1621.
39. Kikuchi A, Yamamoto, Sato A, Matsumoto S, (2011) New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 291: 21-71.
40. Moon RT, Kohn AD, De Ferrari GV, Kaykas A, (2004) Wnt and β-catenin signaling: diseases and therapies. Nature Rev Genetics 5: 689-699.
41. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, et al. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 97: 11960-11965.
42. Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO, (2006) Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase. J Biol Chem 281: 9971-9976.
43. Chen AE, Ginty DD, Fan CM, (2005) Protein kinase A signaling via CREB controls myogenesis induced by Wnt proteins. Nature 433: 317-322.
44. Honjo M, Tanihara H, Inatani M, Kido N, Yue BYJT, et al. (2001) Effects of Rho-associated protein kinase inhibitor, Y-27632, on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42: 137-144.
45. Vittitow JL, Garg R, Rowlette LLS, Epstein DL, O'Brien ET, et al. (2002) Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis 8: 32-44.
46. Liu X, Hu Y, Filla MS, Gabelt BT, Peters DM, et al. (2005) The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis 11: 1112-1121.
47. Zang M, Maddala R, Rao PV, (2008) Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork. Am J Physiol 295: C1057-C1070.
48. Chen J, Runyan SA, Robinson MR, (2011) Novel ocular antihypertensive compounds in clinical trials. Clin Ophthalmol 5: 667-677.
49. Caballero M, Rowlette LL, Borras T, (2000) Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain. Biochim Biophys Acta 1502: 447-460.
50. Jacobson N, Andrews M, Shepard AR, (2001) Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet 10: 117-125.
51. Liu Y, Vollrath D, (2004) Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum Mol Genet 13: 1193-1204.
52. Joe MK, Sohn S, Hur W, Moon Y, Choi YR, et al. (2003) Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun 312: 592-600.
53. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J, (2007) Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol 170: 100-109.
54. Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, et al. (2011) Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest 121: 3542-3553.
55. He Y, Leung KW, Zhou YH, Ge J, (2009) Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells. Mol Vis 15: 815-825.
56. Ezzat MK, Howell KG, Bahler CK, Beito TG, Loewen N, et al. (2008) Characterization of monoclonal antibodies against the glaucoma-associated protein myocilin. Exp Eye Res 87: 376-384.